Point72 Hong Kong LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $2,830 - $3,888	290 Added 483.33%	350 $4,000
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $2,830 - $3,888	290 Added 483.33%	350 $4,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $342 - $513	45 Added 300.0%	60 $1,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $15,568 - $20,707	-1,674 Reduced 99.11%	15 $0
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $1,288 - $1,878	-124 Reduced 6.84%	1,689 $20,000
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $20,650 - $29,424	1,813 New	1,813 $21,000
Q3 2020 Nov 16, 2020	SELL	$15.21 - $25.53 $40,762 - $68,420	-2,680 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $38,650 - $66,638	2,563 Added 2190.6%	2,680 $68,000
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $1,980 - $3,556	-180 Reduced 60.61%	117 $2,000
Q4 2019 Feb 14, 2020	SELL	$5.24 - $12.96 $288 - $712	-55 Reduced 15.63%	297 $3,000
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $5,142 - $10,020	-631 Reduced 64.19%	352 $3,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $12,975 - $20,043	983 New	983 $13,000
Q3 2018 Nov 14, 2018	SELL	$13.23 - $30.93 $3,466 - $8,103	-262 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $4,383 - $5,331	262 New	262 $5,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.